Osteoid osteoma is currently most frequently treated with CT guided radiofrequency ablation (CTgRFA), which is effective, but invasive and exposes the typical young patient population with osteoid osteomas to radiation. Our preliminary results are presented describing MR guided focused ultrasound (MRgFUS) for the treatment of patients with osteoid osteomas. As also reported in two European studies, in our experience, MRgFUS is effective at eliminating pain in these patients. These data form the basis for a proposed clinical trial directly comparing the safety and efficacy of MRgFUS and CTgRFA for treatment of osteoid osteoma.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords